- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.04. | Lilly tumbles on Foundayo's shaky week; FDA to issue vouchers for psychedelics | ||
| 23.04. | FDA approves Regeneron's hearing loss gene therapy | ||
| 23.04. | Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus | ||
| 23.04. | Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs | ||
| 23.04. | Sanofi posts upbeat sales as R&D pressure builds | ||
| 22.04. | Revolution drug shows promise in early pancreatic cancer | ||
| 22.04. | Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial | ||
| 22.04. | Merck adds to pharma's AI push; Roche details MS drug results | ||
| 21.04. | Tortugas debuts with $106M and brain drugs from Hansoh, Eisai | ||
| 21.04. | Merck's fast-ascending kidney cancer drug hits a setback | ||
| 21.04. | BioAge says early data suggest 'best-in-class' potential for inflammation drug | ||
| 21.04. | Trump executive order lifts psychedelics biotechs | ||
| 21.04. | Serif, Flagship's latest biotech, aims to make a new kind of genetic medicine | ||
| 20.04. | RFK Jr. defends HHS tenure, 12% proposed budget cut | ||
| 20.04. | Nektar surges again as alopecia drug shows new promise in extension study | ||
| 20.04. | Lilly boosts 'in vivo' cell therapy capabilities with Kelonia buyout | ||
| 20.04. | AACR 2026: Revolution's next prospect, Merck's reveal and a lung cancer battle | ||
| 20.04. | [Podcast] From Protocol to Patient: Inside Clinical Supply with Almac Clinical Services | ||
| 20.04. | What actually drives speed in complex drug development programs | ||
| 17.04. | UCB, betting on seizure cell therapy, to buy Neurona for up to $1.2B | ||
| 17.04. | Lilly's obesity pill off to a strong start; OpenAI debuts new drug discovery tool | ||
| 17.04. | 5 notable pharma CEO pay hikes in 2025 | ||
| 17.04. | Kailera nets $625M in one of biotech's biggest-ever IPOs | ||
| 17.04. | Erica Schwartz, ex-deputy surgeon general, picked to be next CDC director | ||
| 16.04. | FDA moves toward easing restrictions on certain peptides |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.